Peter Colbourne is an accomplished business development professional with extensive experience in the biopharmaceutical and clinical research industries. Currently serving as the Director of Business Development at ProtaGene since January 2025, Colbourne focuses on analytical development for biological and CGT products. As Managing Director at ConcentRx Consulting since July 2007, Colbourne provides specialized sales and marketing support for service providers in the biopharmaceutical sector. Previous roles include Senior Business Development Manager at WuXi Advanced Therapies and Business Development Consultant at Medicover Integrated Clinical Services, where Colbourne contributed to precision medicine initiatives. Colbourne has also held strategic consulting positions at Genome Explorations Inc., SpeciCare, and LabConnect, enhancing laboratory services and quality assurance. Educational credentials include dual Bachelor of Science degrees in Biochemistry from Memorial University and Dalhousie University, obtained between 1979 and 1986.
This person is not in any teams
This person is not in any offices
ProtaGene
1 followers
ProtaGene is an analytic service provider across the biopharmaceutical, cell, and gene therapy development spaces. They provide complete protein and gene analytic capabilities and packages for biologic therapeutics as well as cell and gene therapy platforms. They offer product testing and analytical packages for product lifecycle management.